A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy

The adoptive transfer of chimeric antigen receptor (CAR) T cell represents a highly promising strategy to fight against multiple cancers. The clinical outcome of such therapies is intimately linked to the ability of effector cells to engraft, proliferate, and specifically kill tumor cells within pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Valton, Julien, Guyot, Valérie, Marechal, Alan, Filhol, Jean-Marie, Juillerat, Alexandre, Duclert, Aymeric, Duchateau, Philippe, Poirot, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817890/
https://www.ncbi.nlm.nih.gov/pubmed/26061646
http://dx.doi.org/10.1038/mt.2015.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817890/
https://www.ncbi.nlm.nih.gov/pubmed/26061646
http://dx.doi.org/10.1038/mt.2015.104

Ejemplares similares